# Erik Hoppe

> Erik Hoppe is a Series A investor at BioVenture backing Fitness and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioVenture](https://shizune.co/investors/profile/bioventure)
- Total investments: 2
- Last investment: Oct 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/erik-hoppe-8207171b/?originalSubdomain=de

Erik Hoppe is a Series A investor at BioVenture focused on Fitness and Health Care. Erik Hoppe is the Executive Partner at Bioventure Management. He attended Free University of Berlin.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Fitness | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Manufacturing | 1 | 50% |
| Product Design | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Repairon | Repairon is a technology firm that specializes in engineering technology and organ repairing solutions. |  | Series A | Oct 02, 2025 |  |
| DiaMonTech AG | DiaMonTech is developing a medical device for non-invasive measurement of blood sugar values. The patented process uses laser technology to determine and control blood glucose values of diabetes patients without any pain and without drawing blood. | $7.1M | Series A | Sep 09, 2019 |  |

2 of 2 investments shown.

## Co-investors
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund, 1 deal together
- [Sartorius](https://shizune.co/investors/profile/sartorius) — VC Fund, 1 deal together

## About BioVenture

VC Fund · Suzhou, China

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

5 contacts available at BioVenture.

| Name | Title | Profile |
| --- | --- | --- |
| Erik Hoppe | Executive Partner | https://shizune.co/investors/profile/erik-hoppe |
| Chen Jie | Founding Partner | https://shizune.co/investors/profile/chen-jie-281b |
| Gaojian Ning | Investment Director | https://shizune.co/investors/profile/gaojian-ning |
| Haihua Huang | Investment Director | https://shizune.co/investors/profile/haihua-huang |
| Jacky Chen | General Manager | https://shizune.co/investors/profile/jacky-chen |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Erik Hoppe invest in?

Erik Hoppe invests primarily in Fitness, Health Care and Biotechnology startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Erik Hoppe last invest?

The most recent investment recorded for Erik Hoppe closed in Oct 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co